24.04.2022, 844 Zeichen

Valneva: Albumedix is expanding its existing collaboration with Austrian/French  Valneva, a specialty vaccine company focused on prevention of infectious diseases with significant unmet medical need.  This announcement comes on the back of the recent approval of Valneva´s inactivated COVID-19 vaccine (VLA2001) by MHRA, for which Valneva signed an agreement in November 2021 with the European Commission to supply up to 60 million doses over two years, as well as announcing an advance purchase agreement with the Kingdom of Bahrain in December 2021 for the supply of one million doses. Albumedix Recombumin rHA is an essential component in VLA2001, used in the manufacturing process and final formulation of the vaccine.
Valneva: weekly performance: -8.08%

(From the 21st Austria weekly https://www.boerse-social.com/21staustria (18/04/2022)

Christian Drastil: Wiener Börse Plausch

Zertifikate Party Österreich: Zeitzeugin Alexandra Baldessarini (Ex-ÖVAG) liest die Zertifikate-Geschichte von 2007 bis 2009

Bildnachweis

Aktien auf dem Radar:Wienerberger, Frequentis, RBI, Austriacard Holdings AG, EuroTeleSites AG, Amag, Rosgix, Zumtobel, Porr, AT&S, Andritz, Heid AG, Rosenbauer, Wolford, Wolftank-Adisa, CPI Europe AG, Österreichische Post, Telekom Austria, UBM, SAP, Rheinmetall, DAIMLER TRUCK HLD..., Fresenius Medical Care, Münchener Rück, Hannover Rück, GEA Group, adidas, Bayer, Hochtief, Siemens Healthineers, Allianz.

---